Holding(s) in Company
UBS Group AG, through UBS AG, has acquired a significant stake in Renalytix PLC, now holding 5.356372% of the voting rights, which equates to 35,912,299 shares. This acquisition crossed a notification threshold on October 15, 2026, and was formally reported on October 19, 2026. Prior to this notification, UBS held no voting rights in the company.
Select text to share a quote on X · sign in to keep highlights & notes in your RENX notes
- Reason for the notification (please mark the appropriate box or boxes with an “X”)
| An acquisition or disposal of voting rights | X |
An acquisition or disposal of financial instruments
An event changing the breakdown of voting rights
Other (please specify) iii :
Details of person subject to the notification obligation iv
| Name | UBS Group AG – Investment Bank & Global Wealth Management |
| City and country of registered office (if applicable) | Zürich Switzerland |
Full name of shareholder(s) (if different from 3.) v
| Name | UBS AG |
| City and country of registered office (if applicable) | London, United Kingdom |
| 5. Date on which the threshold was crossed or reached vi : | 15 October 2026 |
| 6. Date on which issuer notified (DD/MM/YYYY): | 19 October 2026 |
- Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8. A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer (8.A + 8.B) vii | |
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed or reached | 5.356372% | 0.000000% | 5.356372% | 35,912,299 |
| Position of previous notification (if applicable) | 0.000000% | 0.000000% | 0.000000% | |
| A: Voting rights attached to shares | ||||
| Class/type of shares ISIN code (if possible) | Number of voting rights ix | % of voting rights | ||
| Direct (DTR5.1) | Indirect (DTR5.2.1) | Direct (DTR5.1) | Indirect (DTR5.2.1) | |
| GB00BYWL4Y04 | 35,912,299 | 5.356372% | ||
| SUBTOTAL 8. A | 35,912,299 | 5.356372% | ||
| B 1: Financial Instruments according to DTR5.3.1R (1) (a) | ||||
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Number of voting rights that may be acquired if the instrument is exercised/converted. | % of voting rights |
SUBTOTAL 8. B 1
B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)
| Type of financial instrument | Expiration date x | Exercise/ Conversion Period xi | Physical or cash Settlement xii | Number of voting rights | % of voting rights |
|---|---|---|---|---|---|
| SUBTOTAL 8.B.2 | |||||
| Name xv | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | ||
| UBS Group AG | |||||
| UBS AG | 5.356372% | 5.356372% | |||
In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
Additional information xvi
| Place of completion | Zurich, Switzerland |
|---|---|
| Date of completion | 19.10.2026 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.